Simplex Trading, LLC Bio Cardia, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$0.38 - $0.68 $2,738 - $4,900	7,207 New	7,207 $2,000
Q2 2023 Aug 04, 2023	BUY	$1.52 - $2.8 $5,461 - $10,060	3,593 New	3,593 $9,000
Q4 2022 Feb 02, 2023	BUY	$1.61 - $32.1 $2,798 - $55,789	1,738 Added 29.94%	7,543 $15,000
Q3 2022 Nov 04, 2022	BUY	$0.24 - $30.3 $850 - $107,413	3,545 Added 156.86%	5,805 $11,000
Q2 2022 Aug 03, 2022	SELL	$17.7 - $32.55 $10,531 - $19,367	-595 Reduced 20.84%	2,260 $3,000
Q1 2022 May 02, 2022	SELL	$21.3 - $39.0 $168,142 - $307,866	-7,894 Reduced 73.44%	2,855 $5,000
Q4 2021 Feb 23, 2022	BUY	$25.65 - $46.05 $163,595 - $293,706	6,378 Added 145.92%	10,749 $20,000
Q2 2021 Aug 12, 2021	SELL	$48.9 - $74.85 $918,244 - $1.41 Million	-18,778 Reduced 81.12%	4,371 $17,000
Q1 2021 Apr 26, 2021	BUY	$51.3 - $78.15 $1.19 Million - $1.81 Million	23,149 New	23,149 $100,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.